Bernardo Cortese

Bernardo Cortese

Interventional cardiologist / Cardiologist
Director Interventional Coronary Center, University Hospitals Harrington Heart & Vascular Institute - Cleveland, United States of America

Latest contributions

DCB digital crosstalk: practice patterns for patients with diabetes and diffuse disease in Asia

16 Oct 2024

Watch the replay of this webinar on the concept of DCB in native vessel disease and so much more!

Comparative insights into QFR, FFR, and angiography

16 May 2024 – From EuroPCR 2024

This session, comprising selected EuroPCR 2024 Abstract submissions, focuses on various aspects of assessing and managing multivessel coronary artery disease. It includes presentations and discussions on the use of quantitative flow ratio (QFR) for assessing non-culprit lesions in acute myocardial infarction, functional assessment of surgical revascularization,...

Comparative insights into QFR, FFR, and angiography

Evolution of complex PCI: cross, modify it, and be precise!

14 May 2024 – From EuroPCR 2024

Don't miss this session for expert guidance on preparing and managing complex lesions. Gain insights into choosing the right tools, including microcatheters and balloons, for optimal treatment outcomes. Explore the innovative features of flagship devices for complex PCI, and Pronavi microcatheter and Alveo HP CTO balloon...

Evolution of complex PCI: cross, modify it, and be precise!

Hotline: new coronary devices (DES, BRS, DCB)

14 May 2024 – From EuroPCR 2024

This hotline session provides a comprehensive overview of the latest clinical data on new coronary devices, including bioresorbable scaffolds, drug-coated balloons, and drug-eluting stents. Participants will learn about the outcomes of various randomized trials and registry studies, examining the performance of these innovative technologies in different...

Hotline: New Coronary Devices Unveiled

Sirolimus-coated balloon: expanding the scope of indications for complex coronary artery disease treatment

14 May 2024 – From EuroPCR 2024

Watch this session to gain case-based insights on using DCBs in complex settings. Learn valuable tips and tricks for optimal DCB application, including the best timing and situations for their use. Discover how to effectively implement a hybrid strategy that combines DES and DCB when needed.

Sirolimus-coated balloon: expanding the scope of indications for complex coronary artery disease treatment

Current indications for DCB in de novo lesions

18 May 2023 – From EuroPCR 2023

If you are interested in learning more about drug-coated balloon angioplasty in de novo disease, don't miss this informative session, which incorporates real-life cases. The session begins with a comprehensive review of the top five papers published in the past year, focusing on this topic. Additionally,...

Current indications for DCB in de novo lesions

Going down the road of coronary artery disease treatment: sirolimus-coated balloon and DES + DCB stent platform

16 May 2023 – From EuroPCR 2023

What better way to talk about sirolimus-coated balloons than with real-life clinical cases? In this session, study the case of a 78-year-old man with crescendo angina and inferior wall ischaemia, or a 48-year-old woman with crescendo angina, type 2 DM and anterior wall hypokinesia with mild...

Sirolimus coated balloon: expanding the scope of coronary artery disease treatment

07 Oct 2022 – From AICT-ASIAPCR 2022

Consult this session to understand the technology and scientific evidence of the novel sirolimus drug-coated balloon, to learn its utility for PCI in a variety of lesion and patient subsets and to understand the evidence and outcomes in real-world patients.

Sirolimus coated balloon: expanding the scope of coronary artery disease treatment

Treatment of calcified lesions

07 Oct 2022 – From AICT-AsiaPCR 2022

Consider a 66-year-old man, hypertensive and diabetic for 10 years, with history of recurrent substernal chest pain and exertional dyspnea, who presented with easy fatigability and shortness of breath, or a 72-year-old man on dialysis who presented with STEMI and severe calcified stenosis of LAD/DI bifurcation,...

Treatment of calcified lesions

Rotational atherectomy for the treatment of calcified coronary lesion - Session with LIVE case

07 Oct 2022 – From AICT-AsiaPCR 2022

Let's see how this 80-year-old female patient with hypertension, hyperlipidaemia, diabetes mellitus, chronic kidney disease, history of ischaemic heart disease (2018) and NSTEMI (August 2022), currently asymptomatic but mainly homebound, was treated LIVE, and learn more about the treatment of calcified coronary lesion.

Rotational atherectomy for the treatment of calcified coronary lesion

Clinical cases - Coronary interventions - Session 5

07 Oct 2022 – From AICT-AsiaPCR 2022

What's new in treatment of stent failure - a closer look at stent restenosis and thrombosis

This session shows cases from daily practice that illustrate the problems of stent failure from a general perspective. It allows for a better understanding of the mechanisms of stent restenosis & thrombosis on the one hand, and the role of DCBs on the other.

What's new in treatment of stent failure -  a closer look at stent restenosis and thrombosis

EuroPCR 2022 Hotlines / Late-Breaking Trials in Drug-eluting balloons: U-REDUCE STENT, HYPER, IMPROVED-CTO, and more!

19 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in drug-eluting balloons! A Sirolimus-coated balloon with micro-reservoir technology in coronary lesions, utilisation of DEB guided by post-PCI pressure gradient, DEB in combination with DES in the treatment of diffuse coronary artery disease,DEB for in-stent restenosis and plaque...

EuroPCR 2022 Hotlines / Late-Breaking Trials in Drug-eluting balloons: U-REDUCE STENT, HYPER, IMPROVED-CTO, and more!

The current role of paclitaxel DCB in PCI

18 May 2022 – From EuroPCR 2022

Thanks to the different interventions of this EuroPCR 2022 session, understand the role of paclitaxel DCB in modern era interventional cardiology, the differences, and advantages versus DES, the role of blended therapies in CLS, and learn how to correctly prepare the lesion and obtain the best from this technology on...

The current role of paclitaxel DCB in PCI

Sirolimus coated balloon and coronary artery disease: expanding the treatment indications

17 May 2022 – From EuroPCR 2022

Through a case presentation, as well as upcoming studies and rationale for the Food and Drug Administration, the aim of this EuroPCR 2022 session is to help you answer the following questions: how can the use of a sirolimus-coated DCB be expanded in new and challenging treatment indications? Why is...

Sirolimus coated balloon and coronary artery disease: expanding the treatment indications

Sustained Limus release, redefining indications for drug-eluting balloons

20 May 2021 – From EuroPCR 2021

Watch this session presented by Bernardo Cortese, Kambis Mashayekhi, Jonas Häner and Tuomas Rissanen in order to understand how sustained Limus release technology can broaden DEB indications, to learn how SELUTION SLR sustained Limus DEB performs in daily clinical practice, and to know more about the importance of sustained Limus release technology...

Sustained Limus release, redefining indications for drug-eluting balloons

MagicTouch sirolimus coated balloon continues to be the choice of treatment for CAD

19 May 2021 – From EuroPCR 2021

Watch this session presented by Antonio Colombo, Aloke Finn, Sandeep Basavarajaiah, Gianluca Caiazzo and Bernardo Cortese in order to know where to use a DCB in today's clinical practice, to learn about real-world case-based experience and interesting data presentation from various registries and clinical studies, and to understand the technology...

MagicTouch sirolimus coated balloon continues to be the choice of treatment for CAD

The future of PCI seems bright - The MagicTouch sirolimus-coated balloon

18 May 2021 – From EuroPCR 2021

Watch this session presented by Antonio Colombo, Bernardo Cortese and Sandeep Basavarajaiah in order to understand the strategy behind using a DCB as a proper solution for CAD and the result and potential of using a Sirolimus DCB in coronary intervention, as well as to get insights into real...

The future of PCI seems bright - The MagicTouch sirolimus-coated balloon

Sirolimus-coated balloons, an appraisal on its potential advantages over paclitaxel

26 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to learn and understand how and where to use a Sirolimus DCB in current practice, to see clinical evidences and results for the treatment of Patients with Sirolimus DCB and to see the potential advantages of using the Sirolimus over...

Sirolimus-coated balloons, an appraisal on its potential advantages over paclitaxel

Abstracts on stent & scaffolds - PCR e-Course 2020

25 Jun 2020 – From PCR e-Course 2020

View a selection of abstracts from PCR e-Course 2020 on the topic of Stents & scaffolds:

  • 12-month follow-up results of the first cohort of the BIOSOLVE-IV registry
  • The effects of shockwave lithotripsy on DES
  • 5-year data of the drug-eluting absorbable metal scaffold in BIOSOLVE-II
  • Bailout stenting post drug coated balloons;...
Abstracts on Stent & scaffolds - PCR e-Course 2020

Sirolimus-eluting DCB: update from the Eastbourne study

In this short video, Bernado Cortese (Italy) describes the interim analysis of the Eastbourne study, which is evaluating the performance of a sirolimus-eluting DCB for the treatment of any type of coronary lesion, including native vessel disease and in-stent restenosis. The Eastbourne registry is enrolling patients...

New trials in coronary imaging and physiology

23 May 2019 – From EuroPCR 2019

Consult this session to learn all about the new trials and studies in coronary imaging and physiology: FFR-Search, ROCK II, HAWKEYE, and more!

New trials in coronary imaging and physiology

Trials and registries - Clinical outcomes after interventions with drug-coated balloons

21 May 2019 – From EuroPCR 2019

Consult this session to learn more about the results of the latest trials and registries regarding the clinical outcomes after interventions with drug-coated balloons: SCAAR, BASKET-SMALL 2, EASTBOURNE, and more!

Trials and registries - Clinical outcomes after interventions with drug-coated balloons

Transforming DCB strategy: sirolimus-coated balloon with Nanolute technology

21 May 2019 – From EuroPCR 2019

Consult this session on DCB strategy to learn more about the use of sirolimus-coated balloon with Nanolute technology, and to understand its benefits and its future applications in coronary interventions, thanks to the insight from pre-clinical evaluation, various clinical cases and FDA study.

Transforming DCB strategy: sirolimus-coated balloon with Nanolute technology